Noah AI Industry News

Delivers real-time biopharma news and signals — powered by AI, curated for professionals.

J&J's Orthopedics Leadership Shake-up Amid DePuy Spinout Plans

Johnson & Johnson's orthopedics division is undergoing significant changes as the company prepares to spin out its DePuy Synthes business. The departure of a key executive and the appointment of new leadership mark a pivotal moment for the medical device giant.

NoahAI News12/2/2025

Akebia Therapeutics Acquires Q32 Bio's ADX-097 for Rare Kidney Disease Pipeline

Akebia Therapeutics has announced a significant deal with Q32 Bio, acquiring the complement inhibitor ADX-097 for $12 million upfront. This acquisition marks a strategic move for Akebia as it builds its rare kidney disease pipeline, while providing Q32 Bio with additional funds to focus on its alopecia areata program.

NoahAI News12/2/2025

Pfizer's ATTR-CM Sales Decline Signals Market Shift as New Players Gain Ground

The transthyretin amyloid cardiomyopathy (ATTR-CM) market, once heralded as a potential $20 billion opportunity, is showing signs of a slowdown. Pfizer's recent report of a 1% year-over-year sales decline for its tafamidis products in the U.S. has raised questions about the market's trajectory and the impact of new entrants.

NoahAI News12/2/2025

UnitedHealth Group to Sell Latin American Unit Banmedica for $1 Billion

UnitedHealth Group, the healthcare giant, has reached an agreement to sell its Latin American business Banmedica for $1 billion to Brazilian private equity firm Patria Investments. This move marks the company's final exit from South American markets and comes as part of a broader strategy to streamline operations and focus on core businesses.

NoahAI News12/2/2025

European Union and Angelini Industries Launch €150M Healthcare Startup Fund

The European Union has partnered with Italian conglomerate Angelini Industries to establish a significant funding initiative aimed at bolstering healthcare startups across Europe. This collaboration marks a strategic move to enhance the continent's position in healthcare innovation and technology.

NoahAI News12/2/2025

AI Voice Agents Transform Patient Experience at Tampa General Hospital

Tampa General Hospital (TGH) has successfully implemented artificial intelligence (AI) voice agents in its contact center, resulting in significant improvements in patient communication and operational efficiency. The initiative, a collaboration with healthcare AI startup Hyro, has led to faster response times, lower call abandonment rates, and streamlined appointment scheduling within just three months of deployment.

NoahAI News12/2/2025

Regeneron Forges $275M Gene Editing Partnership with Tessera Therapeutics

Regeneron Pharmaceuticals has announced a significant collaboration with Tessera Therapeutics, marking a substantial investment in gene editing technology for the treatment of alpha-1 antitrypsin deficiency (AATD). The partnership, revealed on Monday, centers around Tessera's innovative in vivo gene editor TSRA-196, which has shown promising results in preclinical studies.

NoahAI News12/1/2025

FDA Delays Decision on Ascendis' Dwarfism Drug, Intensifying Competition with BioMarin

The U.S. Food and Drug Administration (FDA) has extended its review period for Ascendis Pharma's achondroplasia treatment, TransCon CNP, by three months. This delay pushes the target action date from November 30, 2025, to February 28, 2026, following the submission of additional information regarding post-marketing requirements.

NoahAI News12/1/2025

AI and Automation Revolutionize Protein Engineering in Next-Generation Biologics

The pharmaceutical industry is witnessing a paradigm shift in protein engineering, driven by artificial intelligence (AI) and advanced automation technologies. As bispecific antibodies, antibody-drug conjugates (ADCs), and novel protein formats move into clinical stages, drug discovery teams are facing new challenges in engineering and producing increasingly complex molecules.

NoahAI News12/1/2025

Virtual Incision Advances Miniaturized Surgical Robot to Challenge Intuitive's Market Dominance

In a rapidly evolving field of surgical robotics, Virtual Incision is positioning itself as a formidable challenger to industry giant Intuitive Surgical. Led by former Intuitive executive Jim Alecxih, the Lincoln, Nebraska-based company is accelerating the development and commercialization of its next-generation miniaturized surgical robot, the M2.

NoahAI News12/1/2025

Belite Bio's Tinlarebant Shows Promise in Phase 3 Stargardt Disease Trial

Belite Bio has announced positive results from its phase 3 trial of tinlarebant, an oral drug candidate for the treatment of Stargardt disease type 1 (STGD1), a rare genetic eye disorder. The success of this trial positions the company to potentially launch the first treatment for STGD1 in the United States, with plans to file for FDA approval in the first half of 2026.

NoahAI News12/1/2025

Protego Biopharma Advances Novel AL Amyloidosis Treatment with $130M Series B Funding

Protego Biopharma, a San Diego-based biotechnology company, has successfully raised $130 million in a Series B funding round to advance its innovative approach to treating amyloid light-chain (AL) amyloidosis. The funding, led by Novartis Venture Fund and Forbion, will propel the company's lead candidate, PROT-001, into late-stage clinical testing, potentially offering a paradigm shift in the treatment of protein misfolding disorders.

NoahAI News12/1/2025

«1...8 9 10...67 »